Brain wave study tests eczema cream vs. water

NCT ID NCT07333300

Completed Knowledge-focused Sponsor: NovoBliss Research Pvt Ltd Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 06, 2026 · Updated 3 times

Summary

This study will use a special headband that reads brain waves to see how adults with mild to moderate atopic dermatitis (eczema) respond to a single application of a marketed cream compared to plain water. Twenty participants will have their brain activity measured for signals related to pain, itching, and discomfort. The goal is to explore whether this technology can detect differences in how the brain processes these sensations after applying the cream.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: marketed topical cream
What this could lead to: If successful, this could help researchers understand how the brain processes itch and discomfort in atopic dermatitis, potentially guiding future treatments.
What could go wrong: This is a very small, early exploratory study with only 20 participants and a single application. It measures brain waves, not clinical improvement, so results may not lead to any direct treatment benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS (AD)

Contacts and locations

Locations

NovoBliss Research

Ahmedabad, Gujarat, 382481, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.